The role of the Qualified Person for Pharmacovigilance (QPPV) has long been central to ensuring that pharmaceutical companies meet their pharmacovigilance (PV) obligations. Acting as the cornerstone of drug safety governance, the QPPV carries ultimate responsibility for the establishment and maintenance of a compliant PV system within the European Union and the United Kingdom.
However, as the pharmaceutical landscape undergoes rapid transformation, the QPPV role is also evolving. Advances in digital health, the growth of real-world evidence, the complexity of global supply chains, and the increasing reliance on automation and artificial intelligence are reshaping the scope of pharmacovigilance. In this context, QPPVs must expand their expertise and adapt to oversee PV systems that are more complex, data-driven, and globally interconnected than ever before.
The Traditional Role of the QPPV
Historically, the QPPV has been responsible for ensuring:
- Continuous oversight of the company’s PV system.
- Review and sign-off of critical safety documents such as the Pharmacovigilance System Master File (PSMF).
- Maintenance of compliance with Good Pharmacovigilance Practice (GVP) requirements.
- Serving as the primary contact point for regulatory authorities.
This role, while already significant, is now broadening in scope to meet the challenges of modern pharmacovigilance.
Drivers of Change
1. Digitalisation of Pharmacovigilance
The adoption of artificial intelligence, machine learning, and automation in case processing and signal detection is transforming PV operations. QPPVs must now demonstrate not only regulatory knowledge but also an understanding of how digital tools integrate into safety systems, and how data integrity is maintained in these environments.
2. Expansion of Global PV Obligations
The globalisation of pharmaceutical development and distribution means QPPVs must oversee PV systems that extend across multiple jurisdictions, each with its own regulatory nuances. This requires stronger coordination with local safety officers and deeper awareness of international requirements.
3. The Rise of Real-World Data
With the growing reliance on data from electronic health records, registries, and digital health tools, QPPVs must adapt to managing new and less structured data sources. Ensuring that real-world data is reliable, traceable, and used appropriately in safety decision-making is becoming a key responsibility.
4. Advanced Therapies and Personalised Medicine
Gene therapies, cell therapies, and personalised medicines introduce unique and often unpredictable safety profiles. QPPVs will need to oversee PV systems capable of capturing and managing long-term and highly specific safety data, often in smaller patient populations.
5. Increased Regulatory Scrutiny
Regulators are placing greater emphasis on proactive safety management, benefit–risk evaluation, and system audits. QPPVs must be prepared to demonstrate oversight not just of processes but of the strategic use of safety data to protect public health.
The Expanding Role of the QPPV
In the digital age, the QPPV is becoming more than a regulatory gatekeeper. The future role will require:
- Digital Competence: Understanding AI, automation, and data science to ensure systems remain compliant and transparent.
- Strategic Leadership: Guiding companies on the integration of PV with broader risk management and corporate governance frameworks.
- Global Coordination: Overseeing distributed teams and aligning global PV operations with regional regulatory expectations.
- Patient-Centric Oversight: Leveraging patient-reported outcomes and digital health data to enhance safety monitoring.
- Continuous Learning: Keeping pace with evolving therapies, technologies, and regulations.
How Q&V Can Support QPPVs
At Quality and Vigilance, we understand the increasing pressures on QPPVs and the evolving complexity of pharmacovigilance systems. Our services include:
- Expert support in digital PV transformation and audit readiness.
- Guidance on managing real-world data and advanced therapy monitoring.
- Training and capacity-building for PV teams to align with QPPV expectations.
- Strategic advice on maintaining compliance across multiple jurisdictions.
By working alongside QPPVs, we enable organisations to strengthen oversight, mitigate risk, and remain at the forefront of pharmacovigilance in an increasingly digital and patient-centred world.